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Interval Estimation for Messy
Observational Data
Paul Gustafson and Sander Greenland
Abstract. We review some aspects of Bayesian and frequentist interval
estimation, focusing first on their relative strengths and weaknesses
when used in “clean” or “textbook” contexts. We then turn attention to
observational-data situations which are “messy,” where modeling that
acknowledges the limitations of study design and data collection leads
to nonidentifiability. We argue, via a series of examples, that Bayesian
interval estimation is an attractive way to proceed in this context even
for frequentists, because it can be supplied with a diagnostic in the form
of a calibration-sensitivity simulation analysis. We illustrate the basis
for this approach in a series of theoretical considerations, simulations
and an application to a study of silica exposure and lung cancer.
Key words and phrases: Bayesian analysis, bias, confounding, epi-
demiology, hierarchical prior, identifiability, interval coverage, obser-
vational studies.
1. INTRODUCTION
The conventional approach to observational-data
analysis is to apply statistical methods that assume
a designed experiment or survey has been conducted.
In other words, they assume that all unmodeled
sources of variation are randomized under the de-
sign. In most settings, deviations of the reality from
this ideal are dealt with informally in post-analysis
discussion of study problems. Unfortunately, such
informal discussion seldom appreciates the potential
size and interaction of sources of bias and, as a con-
sequence, the conventional approach encourages far
too much certainty in inference (Eddy, Hasselblad
and Schachter, 1992; Greenland, 2005, 2009; Green-
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land and Lash, 2008; Molitor et al., 2009; Turner et
al., 2009).
The entrenchment of the conventional approach
derives in part from the fact that realistic models
for observational studies are not identified by the
data, a fact which renders conventional methods and
software useless (except perhaps as part of a larger
fitting cycle). The most commonly proposed mode
of addressing this problem is sensitivity analysis,
which, however, leads to problems of dimensional-
ity and summarization. The latter problems have in
turn been addressed by Bayesian and related infor-
mal simulation methods for examining nonidentified
models (which are often dealt with under the topic
of nonignorability). These methods include hierar-
chical (multilevel) modeling of biases (Greenland,
2003, 2005), which is intertwined with the theme of
the present paper.
We start in Section 2 by reviewing some notions
of interval estimator performance, with emphasis on
coverage averaged over different parameter values.
Section 3 then extends this discussion to include in-
tervals arising from hierarchical Bayesian analysis
when data from multiple studies are at hand. These
two sections reframe existing theory and results in a
manner suited for our present needs. We emphasize
a well-known tradeoff: To the extent the selected
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prior distribution is biased relative to reality, the
coverage of a Bayesian posterior interval will be off,
but perhaps not by much; and in return the inter-
vals can deliver substantial gains in precision and re-
duced false-discovery rates compared to frequentist
confidence intervals. In addition, hierarchical priors
provide a means to reduce prior misspecification as
studies unfold.
In Section 4 we turn to the more novel aspect
of our work, by studying the case which we believe
better captures observational-study reality, in which
priors are essential for identification. Here the usual
order of robustness of frequentist vs. Bayesian pro-
cedures reverses: Confidence intervals become only
extreme posterior intervals, obtained under degener-
ate priors, with coverage that rapidly deteriorates as
reality moves away from these point priors. In con-
trast, the general Bayesian framework with proper
priors offers some protection against catastrophic
undercoverage, with good coverage guaranteed un-
der a spectrum of conditions specified by the inves-
tigator and transparent to the consumer. Section 5
summarizes the lessons we take away from our ob-
servations and makes a recommendation concerning
the practical assessment of interval estimator per-
formance. We conclude that Bayesian interval es-
timation is an attractive way to proceed even for
frequentists, because its relevant calibration proper-
ties can be checked in each application via simula-
tion analysis. We close with an illustration of our
proposed practical approach in an application to a
study of silica exposure and lung cancer in which an
unmeasured confounder (smoking) renders the tar-
get parameter nonidentified.
2. THE WELL-CALIBRATED LAB
Let θ denote the parameter vector, and D the ob-
servable data, for a study that is to be carried out.
Assume for now that the distribution of (D|θ)(i.e.,
“the model”) is known correctly. Say that φ= g(θ)
is the scalar parameter of interest, and that I(D)
is an interval estimator for this target. We define
the labwise coverage (LWC) of I with respect to a
parameter-generating distribution (PGD) P as
C(I,P ) = Pr{φ ∈ I(D)}.(1)
Here the probability is taken with respect to the
distribution of (θ,D) jointly, with θ ∼ P and (D|θ)
following the model distribution.
Interval coverage with respect to a joint distribu-
tion on parameters and data, as in (1), has been
considered by many authors, but not with a consis-
tent terminology. While it might be temping to refer
to (1) as “Bayesian” coverage, we find this confus-
ing since (1) can be evaluated for Bayesian or non-
Bayesian interval estimators. We choose to call it
labwise coverage since C(I,P ) is the proportion of
right answers reported by a lab or research team
applying estimator I in a long series of studies of
different phenomena (different exposure-disease re-
lationships, say) within a research domain. The role
of the PGD P is then to describe the corresponding
across-phenomena variation in the underlying pa-
rameter values. Interest in labwise coverage might
be very direct in some contexts, in that estimator
operating characteristics in a long sequence of ac-
tual studies really are the primary consideration. Or
interest may be more oblique, in that performance
on the “next” study is of interest, and this perfor-
mance is being measured conceptually by regarding
the next study as a random draw from the popula-
tion of “potential” or “future” studies.
If I is a frequentist confidence interval (abbrevi-
ated FCI), then it will attain nominal coverage ex-
actly for any PGD. That is, if Pr{φ ∈ I(D)|θ} =
1− α for every value of θ, then C(I,P ) = 1− α for
any P . Thus, correct coverage for a hypothetical se-
quence of studies with the same parameter values
implies correct coverage in the more realistic setting
of repeatedly applying a procedure in a sequence
of differing real problems. While this fact is often
viewed as a robustness property of an FCI, Bayarri
and Berger (2004), citing Neyman (1977), empha-
size that it is the labwise coverage that is relevant
for practice. Put another way, if a lab is well cali-
brated in the LWC sense of producing 95% intervals
that capture the true parameter for 95% of stud-
ies, and the cost of failing to capture is the same
across studies (as might be the case in some genome
studies or screening projects), there is little obvious
benefit if the intervals happen to also have correct
frequentist coverage.
2.1 Bayesian Intervals under PGDs
For a given choice of prior distribution Π on the
parameter vector θ, a 1−α Bayesian posterior credi-
ble interval (BPCI) for the target parameter φ would
be any interval having Bayesian probability 1−α of
containing φ given the observed data D. The most
common choices of BPCI are the equal-tailed BPCI
(i.e, the interval formed by the α/2 and 1 − α/2
posterior quantiles of the target parameter), and
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the highest-posterior-density (HPD) BPCI. Though
HPD intervals are optimally short, we consider only
equal-tailed intervals here, given their simple inter-
pretation and widespread use.
If the prior Π and the PGD P coincide, then a
BPCI is guaranteed to have correct labwise cover-
age. This strikes us as a fundamental property of
BPCIs, though it is surprisingly unemphasized in
most introductions to Bayesian techniques. Hence-
forth, we refer to a BPCI arising from a prior dis-
tribution set equal to the PGD as an omniscient
or “oracular” BPCI (abbreviated OBPCI), in the
sense that the investigator is omniscient in know-
ing the actual PGD giving rise to future studies. It
is indeed a fanciful assumption to think that the
PGD would be known exactly, so throughout this
paper we pay much attention to nonomniscient BP-
CIs (abbreviated NBPCI). That is, we will evaluate
lab-wise coverage when the investigator’s prior dis-
tribution Π differs from the PGD P .
It is worth noting that BPCIs have desirable prop-
erties from a decision-theoretic point of view. The sit-
uation is complicated in that both coverage and
length must be reflected in the loss function. Hence,
this function must be bivariate, or be a univariate
combination of coverage and length terms (which
would necessitate some weighting of the two). Robert
(1994) gives some general discussion of this point.
Despite this complication, there are still results which
link, and come close to equating, BPCIs and admis-
sible interval estimators (see, for instance, Meeden
and Vardeman, 1985). Thus, the common argument
for Bayesian point estimators having desirable fre-
quentist properties does extend, albeit with compli-
cations, to the case of interval estimators.
Additionally, there are large-sample results say-
ing that in “regular” modeling situations with large
sample sizes and priors with unrestricted support,
BPCIs will have frequentist coverage that converges
to nominal coverage, at every possible set of param-
eter values. These results are based on obtaining
a likelihood that dominates the prior given enough
data; as such, they are not very useful for our pur-
poses, because later we turn to problems in which
no such domination occurs. We will however find use
for a variant of this result in which information is
accumulated over a sequence of studies. First, how-
ever, we illustrate the operating characteristics of
some interval estimators in a simple but relevant
situation.
2.2 Example: Mixture of Near-Null and
Important Effects
Say that θ represents the strength of a putative
exposure-disease relationship (which may indeed be
one of a sequence of such exposure-disease combi-
nations to be investigated). For instance, θ might
be a risk difference or a log odds-ratio relating bi-
nary exposure and disease variables. Suppose that
D is a univariate sufficient statistic such that D|θ ∼
N(θ,σ2) where σ2 is known. Then (D± qα/2σ) can
be reported as a 100 × (1 − α)% frequentist confi-
dence interval (FCI) for θ, where qα/2 is the 1−α/2
standard normal quantile.
In the context of observational epidemiology, null
or minimal effects are common, and large effects
are rare. Thus, the PGD giving rise to a sequence
of studies might have most of its mass at or near
zero. For instance, say the PGD is a mixture of two
normal distributions: N(0, ε2) with weight p and
N(0, k2ε2) with weight 1 − p, for a “small” ε and
k > 1. This is interpreted as the first component gen-
erating minimal or near-null associations, while the
second gives rise to important as well as near-null as-
sociations, for example, |θi|< 2ε and |θi|> kε might
reasonably be described as near-null and important
respectively.
We simulate 500,000 parameter-data ensembles with
ε = 0.05, p = 0.85, k = 8, and σ2 = 0.025. If θ is a
log odds-ratio, then these values have exp(θi) within
(0.91,1.1) as near-null, and exp(θi) outside (0.67,1.5)
as important. The choice of σ2 = 2/((500)(0.2)(0.8))
approximates the amount of information for the log
odds ratio when comparing two independent groups
(as in an unmatched case-control study) with 500
subjects per group and exposure prevalences around
20%.
The first two rows of Table 1 give operating char-
acteristics of the FCI and the (equal-tailed) OBPCI
as interval estimators for θ (both at the nominal 95%
level). Note that when used as the prior distribution
for θ, the mixture distribution is conjugate, so that
computation of the OBPCI is straightforward. As
is consistent with theory, the labwise coverages of
both procedures are within simulation error of the
nominal 95%. On average, though, the OBPCI is
considerably shorter than the FCI, by almost a fac-
tor of two. This results from the infusion of prior
information.
Motivated by taking |θ|< 2ε as a minimal effect,
we also define the total discovery rate (TDR), false
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Table 1
Frequency properties of interval estimators based on 500,000 simulated parameter-data pairs from PGD with ε= 0.05,
p= 0.85, k = 8. The “omniscient” posterior (OBPI) uses these parameter values; the “nonomniscient” posterior (NBPI)
uses the values of p and k shown∗
Coverage % Avg. length TDR % FDR % FNR %
FCI 95.0 0.62 6.3 17.0 11.5
OBPI 95.0 0.33 2.2 0.6 14.1
NBPI:
p= 0.50, k = 4 95.8 0.41 2.1 0.5 14.2
p= 0.50, k = 12 97.3 0.46 3.2 2.5 13.3
p= 0.95, k = 4 89.8 0.24 0.9 0.0 15.2
p= 0.95, k = 12 91.7 0.26 1.8 0.2 14.4
N(0, ν2) 94.8 0.44 2.1 0.6 14.1
N(0,0.5ν2) 92.1 0.36 0.8 0.0 15.2
N(0,2ν2) 96.5 0.51 3.5 3.4 13.0
∗Simulation standard errors for coverage, TDR ≈ 0.04%. The simulation standard errors for FDR are considerably larger and
variable, since only a small portion (the TDR) of the simulated pairs contribute to the estimated proportion.
discovery rate (FDR) and false nondiscovery rate
(FNR) for interval estimation as follows: The TDR
is simply the proportion of reported intervals that
exclude the minimal range, that is, give confidence
that the effect is not minimal. The FDR is then the
proportion of these “discoveries” that are false, that
is, in which the parameter actually does lie in the
minimal range. Similarly, amongs intervals intersect-
ing the minimal range, the FNR is the proportion
for which the target is actually outside this range.
We can then describe how the OBPCI is more con-
servative than the FCI: The OBPCI attains a lower
FDR at the cost of a higher FNR, as evidenced in
the first two rows of Table 1.
Investigators are not omniscient. To illustrate con-
sequences of defective prior information, we examine
results in which the prior distribution deviates from
the PGD. Our example is far from a comprehensive
study of prior misspecification, and we doubt that
such a study could be done given all the contex-
tual elements involved. Rather, we wish to illustrate
some qualitative points that will be relevant later,
regarding potential consequences of such misspecifi-
cation.
Two sets of NBPCI results are given in Table 1.
The first set corresponds to an investigator using the
same form of a mixture-normal prior with the cor-
rect value of ε (which defines the notion of a minimal
effect and so is contextually established), but with
misspecified values of p and k (choosing p = 0.50
or p = 0.95, and k = 4 or k = 12). The second set
corresponds to an investigator who does not eluci-
date a mixture structure for the prior, but rather
simply applies a mean-zero normal prior. The case
where the prior variance τ2 equals the PGD vari-
ance of ν2 = pε2 + (1− p)k2ε2 is considered, as are
the cases where the prior variance is half/double the
PGD variance. The results in Table 1 underscore
the disadvantage of the NBPCI relative to the FCI
and the unattainable OBPCI: The labwise cover-
age now deviates from nominal. Arguably, however,
these deviations are modest. Moreover, the NBPCI
tend to maintain the other attractive features seen
with the OBPCI, namely, the much shorter average
length and lower FDR compared to the FCI. Note
that the deviations from nominal coverage are less
pronounced and tend toward conservatism when the
prior is more spread out than the PGD (p = 0.50
in the first set of results, τ2 = 2ν2 in the second).
This is not surprising, since NBPCIs will resemble
FCIs more and more in the “flat” prior limit. In con-
trast, the deviations can be markedly anticonserva-
tive when the prior is more concentrated (p = 0.95
in the first set, τ2 = 0.5ν2 in the second). Thus, by
using very dispersed priors, we can improve the pre-
cision and reduce the FDR of our intervals with-
out incurring objectionable deviations from nominal
coverage. If, however, we “get greedy” and attempt
to improve performance by using overconfident pri-
ors, we risk unacceptable deterioration of coverage.
In this and subsequent examples, we have used
equal-tailed BPCIs because these are intuitive and
commonly reported. It is well known, however, that
for a given data set the HPD interval (or possibly
region) is the shortest interval with the specified
Bayesian probability content. In fact, Uno, Tian and
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Wei (2005) prove an interesting result about labwise
coverage of HPD intervals, in the case that the prior
and PGD coincide. They show that the HPD inter-
val with coverage 1 − α does not always minimize
average width subject to obtaining labwise coverage
1− α. Rather, the minimizing procedure in general
involves the HPD interval with coverage 1− α(D),
such that E{α(D)} = α, where the data-dependent
coverage level α(D) arises by thresholding the poste-
rior densities for all studies at the same cutoff value.
Thus, in cases where the width of the posterior den-
sity varies across studies, HPD intervals with higher
(lower) coverage levels will be reported for studies
with narrower (wider) posterior densities. While we
do not pursue this further here, it is worth empha-
sizing that the simple and intuitive interpretations
associated with using a BPCI of fixed coverage level
can be sacrificed in order to obtain intervals which
are narrower on average.
Given the performance issues illustrated in Table
1, we find it overly simplistic to argue against the use
of Bayesian interval estimation simply because prior
specification is required, and because it is impossible
to get this specification exactly right in terms of
matching the PGD. Furthermore, as we discuss in
the next section, by using a hierarchically structured
prior, one can effectively move the prior closer to the
PGD as a sequence of studies unfolds.
3. HIERARCHICAL PRIOR DISTRIBUTIONS
As we have emphasized, consideration of a se-
quence of studies is a conceptual device capturing
the reality facing most investigators. Studies in
medicine and public health are nowhere near iden-
tical in design, conduct and population studied and,
hence, there is no basis for asserting parameter equal-
ity across these studies. This fact is the rationale
for random-effects models in meta-analysis, which
typically employ very simple models for the PGD.
When a new study is performed, however, data from
m previous studies can be used to improve the prior
distribution for θ by using a hierarchically struc-
tured prior distribution, which in turn will make the
labwise coverage closer to nominal (as m increases,
particularly). This further strengthens the frequen-
tist appeal of Bayesian intervals.
Say that the study to be carried out has parameter-
data ensemble (D,θ) and is preceded by m earlier
studies with ensembles (D∗
1
, θ∗
1
), . . . , (D∗m, θ
∗
m). If the
m+1 ensembles are independent and identically dis-
tributed (i.e., each according to the PGD and the
data model), it makes sense to allow the interval es-
timator for θ to depend on the earlier data as well
as the current data. The labwise coverage (1) then
generalizes to
C(I,P ) = Pr{φ ∈ I(D;D∗)},(2)
whereD∗ = (D∗
1
, . . . ,D∗m) and the probability is taken
with respect to the joint distribution of the m+ 1
parameter-data ensembles.
The standard Bayesian approach to borrowing
strength across studies involves a hierarchical prior.
That is, the prior Π asserts that the m+ 1 compo-
nents of (θ∗, θ) are independent and identically dis-
tributed given a further parameter vector λ. Then λ
itself is assigned a prior distribution. Application of
Bayes theorem to form the posterior distribution on
θ involves the likelihood contribution of D|θ, with
Π(θ|D∗) =
∫
Π(θ|λ)Π(λ|D∗)dλ playing the role of
the prior. That is, the earlier studies inform the
value of λ, which in turn informs θ, in advance of ob-
serving D. If the PGD is well approximated by the
posited (θ|λ) prior for some value of λ (say, λ0), and
if the number of previous studies m is large, then
Π(λ|D∗) should be concentrated near λ0. Thus, the
“effective prior” being applied to θ will be close to
the PGD, which should result in labwise coverage
for BPCIs that is close to nominal.
The use of hierarchical priors to “borrow strength”
across studies and the evaluation of coverage along
the lines of (2) originates under the rubric of “em-
pirical Bayes” procedures (see, for instance, Morris,
1983), which typically involve a non-Bayesian ap-
proximation to Π(λ|D∗). With the advent of bet-
ter algorithms and machines for Bayesian compu-
tation, however, fully Bayesian “hierarchical model-
ing” is now commonplace. It should also be noted
that treating the parameter values for the m + 1
studies as exchangeable as described is a modeling
assumption that will sometimes be inappropriate.
Notably, in a situation where all studies focus on the
same relationship at different calendar times, the as-
sumption may be dubious but may be weakened to
allow for trends. For instance, the “Ty Cobb” ex-
ample in Morris (1983) involves explicit modeling
of a time trend for parameter values corresponding
to consecutive calendar years. Analogously, the as-
sumption may be weakened to allow for group ef-
fects; for example, the occupational-cancer exam-
ple in Greenland (1997) explicitly models changes
in association over cancer type and exposure type.
In such examples it is a residual component of the
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study parameters (after time or group effects are re-
gressed out) that is assumed exchangeable. The ex-
changeability inherent in assuming the original study
parameters are conditionally i.i.d. would be appro-
priate only if no important information is conveyed
by the time order or other known and varying char-
acteristic of the parameters being modeled as an en-
semble.
To give a simple illustration, suppose again that
D|θ ∼ N(θ,σ2) with σ2 known. For computational
ease we first consider a simpler PGD than previ-
ously, namely, a N(λ0, τ
2) distribution. Consider a
partially omniscient investigator who knows the vari-
ance of the PGD, but not the mean, and in hierar-
chical fashion assigns the prior θ|λ ∼ N(λ, τ2), λ ∼
N(δ,ω2). The marginal prior distribution is then
θ ∼N(δ, τ2+ω2). In the absence of previous studies,
or with an i.i.d. prior assuming independence of θ
and θ∗, the posterior on θ would arise from combin-
ing this prior with D, and the discrepancy between
this prior and the PGD would induce some degree
of non-nominal labwise coverage. With a correct hi-
erarchical prior, however, the previous data will pull
Π(λ|D∗) toward λ0, and hence pull Π(θ|D
∗) toward
the PGD.
The present setting is sufficiently simple that the
LWC given in (2) can be computed directly (one-
dimensional numerical integration is required, but
repeated simulation of data is not). As an exam-
ple, suppose σ = 1, and the PGD has λ0 = 3, τ = 1.
Consider four prior distributions for λ, with ω = 1,
and δ = 0,1,2,3. Note that these priors range from
very bad (mean of the PGD lies three prior stan-
dard deviations away from the prior mean) to un-
realistically good (mean of the PGD coincides with
the prior mean). Figure 1 illustrates the coverages
Fig. 1. Labwise coverage and interval length for the nominal
95% BPCI, as a function of the number of previous studies
m. Coverage is given for four choices of hyperparameter δ,
whereas the length does not depend on δ. The dashed horizon-
tal line in the second panel corresponds to the length of the
OBCPI.
(2) for the resulting 95% BPCIs, as the number of
previous studies m increases. When m= 0 (thought
of as either no previous studies, or as an i.i.d. prior
across studies), the coverage ranges from less than
80% for the “worst” prior to somewhat above 95%
for the “best” prior. As Figure 1 illustrates, how-
ever, for all the priors the coverage converges quite
quickly to the nominal 95% as m increases, to match
the OBPCI coverage. The figure also displays the in-
terval width as a function ofm. In this simple setting
the width is governed by
Var(θ|D,D∗)
= σ2τ2(σ2 + τ2)−1
(3)
× [1 + σ2ω2τ−2{(m+ 1)ω2
+ σ2 + τ2}−1],
which depends on neither the observed data nor the
hyperparameter δ. Note that by m= 30 most of the
potential reduction in width has been realized, that
is, the width is close to the OBPCI width which
corresponds to the m→∞ limit of (3). While the
convergence of coverage and length to match the
OBPCI represents a well-known calibration feature
of Bayes and empirical-Bayes estimation, it is inter-
esting to see how rapidly it can proceed in simple
settings.
Of course, the above illustration is very simplistic,
particularly as the variance components involved in
the prior are taken to be known, and only the mean
of the PGD must be learned via previous data. At
the other end of the spectrum, one anticipates that
complex PGDs, such as those involving a mixture of
near-null and important effects, will require a larger
number of studies before they are estimated well.
To investigate this, we reconsider the example of
the previous section, involving a mixture of near-
null and important effects. Now, however, we treat
(p, k) as unknown parameters with prior distribu-
tions p ∼ Uniform(0,1) and k ∼ Uniform(4,20). As
before, the PGD is based on p= 0.85 and k = 8. Em-
pirical results on coverage and average length appear
in Table 2. These are based on only 1000 simulated
parameter-data meta-ensembles (with each meta-
ensemble encompassing m + 1 parameter-data en-
sembles), since the posterior computation is burden-
some. In particular, a simple Markov chain Monte
Carlo algorithm (with random walk proposals) is ap-
plied to sample from (p, k|D,D∗), while (θ|p, k,D,
D∗) = (θ|p, k,D) can be sampled from directly. Re-
sults for coverage are quite appealing, in that the
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labwise coverage (2) modestly exceeds nominal when
the number of previous studies m is small, presum-
ably because Π(θ|D∗) is very flat, and also modestly
exceeds nominal when m is large, presumably be-
cause Π(θ|D∗) is close to the PGD. However, the
very slow convergence of Π(θ|D∗) to the PGD is
manifested by the average interval width. Even with
m= 100 previous studies, the average width is still
44% larger than that of the OBCI. Nonetheless, it is
23% narrower than the FCI, a worthwhile gain paid
for by a minor conservatism.
There are many examples of hierarchical modeling
in the literature, where unknown means and vari-
ances are themselves modeled via prior distributions
or estimated via marginal likelihood. These meth-
ods have performed quite well in large-scale simu-
lations and in applications that provide subsequent
validation (Brown, 2008). Special methodology for
inference about the distribution of a sequence of ef-
fects has expanded apace, driven by work on mul-
tiple comparisons (and particularly false discovery
rates) in genome studies (see, for instance, Efron et.
al., 2001 and Newton and Kendziorski, 2003).
We have emphasized that formal inclusion of pre-
vious studies on various phenomena within a re-
search team’s domain of study can have positive
benefits for subsequent studies within this domain,
in terms of both labwise coverage and average width.
Consequently, a formal scheme to obtain a prior
which is close to the PGD for a given domain seems
desirable when practical. In other circumstances, how-
ever, it should be possible to informally use previ-
ous studies in constructing a reasonable prior distri-
bution. As alluded to earlier, for instance, in many
sub-fields of epidemiology investigators do have well-
grounded notions concerning the across-study preva-
lence of near-null effects and magnitude of impor-
tant effects. One anticipates that a prior formed
from direct elicitation of the investigators’ views
should not deviate greatly from a prior formed from
Table 2
Empirical properties of interval estimators with a prior
distribution on (p, k) and m previous studies. Results based
on 1000 simulated parameter-data meta-ensembles
m Coverage % Avg. length
0 96.4 0.515
10 95.9 0.491
20 95.8 0.487
100 95.4 0.476
formally updating a “flat” prior based on previous
studies. Regardless of which route is taken, construc-
tion of a prior which is reasonably close to the PGD
for future studies in the domain seems to be a realis-
tic and worthwhile goal. With this encouraging mes-
sage in hand, we now turn to examining the use of
Bayesian interval estimators in nonidentified model
settings.
4. INTERVAL ESTIMATION IN
NONIDENTIFIED MODELS
The case for BPCIs versus FCIs seems mixed thus
far, particularly as FCIs are guaranteed to have cor-
rect labwise coverage, without requiring any knowl-
edge of the PGD. But in a large class of statisti-
cal problems, construction of valid FCIs is not pos-
sible. Recall that in general a model is noniden-
tified if there are multiple sets of parameter val-
ues giving rise to the same distribution of observ-
ables. We have argued that this class of models is
the only realistic choice in most observational stud-
ies of human health and society (Greenland, 2005;
Gustafson, 2006). This is particularly true in disci-
plines such as epidemiology where honest appraisal
of what modeling assumptions are justified, and what
limitations are inherent in the available data, ought
to lead investigators to nonidentified models rou-
tinely.
Identifiable models are desirable when they can
supply root-n consistent estimators of target pa-
rameters, as in classic industrial and laboratory ex-
periments. With study problems such as measure-
ment error, missing data, selection bias and unmea-
sured confounders, however, extremely strong as-
sumptions may be required to attain an identified
model. Most statistical methods assume absence of
such problems, and the remainder assume that the
form of the problems is known up to a few identifi-
able parameters. Either way, there is a strong pos-
sibility that the resulting model is grossly misspec-
ified, with the resulting FCIs exhibiting excessive
precision and severe undercoverage for the inferen-
tial target.
Put another way, using an overly simplified model
for the sake of identifiability results in root-n consis-
tent inference for the wrong parameter (e.g., an un-
conditional association, when the desired inferential
target is an association conditional on an unmea-
sured covariate) (Greenland, 2003, 2005; Gustafson,
2006). If, as usual, the parameter being estimated
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does not equal the target parameter, the interval
coverage for the latter will tend to zero as the sam-
ple size increases.
Backing away from untenable assumptions may
result in a model that is better specified (closer to
reality, or at least better representing the true infer-
ential target), but which lacks identifiability. There
is extreme hesitance among statisticians regarding
the use of nonidentified models, because they do not
give rise to estimators with familiar statistical prop-
erties, such as root-n shrinkage of interval estima-
tors to some value. But for Bayesian analysis there
is no conceptual or computational difference in how
inferences are obtained from a nonidentified model
compared to an identified model. In fact, from a
radical subjective Bayesian perspective, identifica-
tion is a matter of a degree and always a function of
the full prior (including the prior for the data given
the parameters).
In summary, in nonidentified problems there is no
route to FCIs achieving exactly nominal coverage for
any set of underlying parameter values. If in these
settings we simplify the model to the point of identi-
fiability, then FCIs are readily obtained via standard
methods, but are likely to have grossly incorrect cov-
erage probabilities due to misspecification. Without
simplification, models are nonidentified, which pre-
cludes construction of FCIs having the nominal cov-
erage probability at every point in the parameter
space.
Some frequentist approaches to problems of this
sort involve (i) specifying bounds (rather than prior
distributions) on key parameters, and (ii) construct-
ing interval estimators having at least nominal cov-
erage at every point in the parameter space, with the
consequence that the coverage will be higher than
nominal at most parameter values. Some recent sug-
gestions along these lines include Imbens and Man-
ski (2004), Vansteelandt et al. (2006) and Zhang
(2009); we illustrate such an approach in the first
of the two examples below. Conversely, the use of
Bayesian or approximately Bayesian inferences from
nonidentified models was suggested at least as far
back as Leamer (1974), and has long been discussed
under special topics such as nonignorable missing-
ness (Little and Rubin, 2002). It has also attracted
considerable attention in recent literature; see, for
instance, Dendukuri and Joseph (2001); Greenland
(2003, 2005); Gustafson (2005b); Gustafson and
Greenland (2006a, 2006b); Hanson, Johnson and
Gardner (2003); Joseph, Gyorkos and Coupal (1995);
McCandless, Gustafson and Levy (2007, 2008); Scharf-
stein, Daniels and Robins (2003).
For Bayesian procedures, the exact attainment of
nominal labwise coverage by an OBPCI still holds
under nonidentified models. The result in general
(for any kind of model) is known, but surprisingly
unemphasized in the literature (see Rubin, 1984,
and Rubin and Schenker, 1986, for exceptions). Yet
it seems to be a useful reference point, as it provides
a clear calibration, or “anchor,” for an interval esti-
mation procedure in a nonidentified model. On the
other hand, we generally expect the choice of prior to
be far more influential on the posterior distribution
when the model is nonidentified, so that lab-wise
coverage may deviate rapidly from nominal as the
prior distribution deviates from the PGD. We inves-
tigate this phenomenon in the two examples below.
4.1 Example: Prevalence Survey
with Nonresponse
Vansteelandt et al. (2006) illustrate some frequen-
tist techniques for sensitivity analysis in nonidenti-
fied models in the following setting. A binary out-
come Y may be observed (R= 1) or missing (R= 0,
nonresponse) for each study unit, so that the avail-
able data consist of n i.i.d. realizations of (RY,R).
The inferential target is the outcome prevalence,
pi =Pr(Y = 1), while the missingness may be infor-
mative, that is, Y and R may be associated. One
parameterization for this situation is p=Pr(R= 1),
s = Pr(Y = 1|R = 1), and γ = logit{Pr(Y = 1|R =
0)} − θ where θ = logit(s). Then the inferential tar-
get is pi = (1 − p) expit(θ + γ) + ps. This is a non-
identified inference problem because the likelihood
for the observed data depends only on p and s, while
the inferential target also depends on γ.
We consider the coverage and average length of
three interval estimators for pi. The first is the na¨ıve
interval estimator obtained by assuming γ = 0, that
is, assuming the missingness is completely at ran-
dom, and estimating pi as the sample proportion of
the observed outcomes. The second is an interval
estimator suggested by Vansteelandt et al. (2006),
designed to have at least nominal frequentist cov-
erage (approximately) under every fixed value of γ
in a specified interval I ; we take I = (−2,2) in the
present example. Let pˆil and pˆiu be the estimates
of pi when fixing the value of γ at the lower and
upper endpoints of I respectively. Then the inter-
val estimator with target level 1− α is of the form
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(pˆil− qα∗/2se(pˆil), pˆiu+ qα∗/2se(pˆiu)), where α
∗ is cho-
sen to make the minimum coverage as γ varies in
I equal to 1 − α (with the minimum attained at
one of the endpoints). We refer to this interval as a
conservative frequentist confidence interval (CFCI).
The relationship between α∗ and α depends on the
unknown parameters, hence, estimates are plugged
in and the coverage properties become approximate
rather than exact. Vansteelandt et al. (2006) call in-
terval estimators of this form “pointwise estimated
uncertainty regions,” since the coverage claim ap-
plies to the true value of the target parameter. These
authors also propose “weak” and “strong” estima-
tors with coverage claims pertaining to the set of
all target parameter values consistent with the ob-
served data law (i.e., interval estimation of an inter-
val). For more details see Vansteelandt et al. (2006).
The third interval estimator is the equal-tailed
Bayesian credible interval arising from a uniform
prior distribution for γ on the same interval I , along
with uniform(0,1) priors for both p and s. Under
this specification the parameters p, s and γ remain
independent of one another a posteriori, with beta
distributions for p and s arising from binomial up-
dating, and a uniform posterior distribution on I for
γ; that is, no updating of γ occurs.
Empirical labwise coverage and average length for
nominal 95% intervals are given in Table 3. The PGDs
used have normal distributions for β = logit(p) and
θ = logit(s) with µβ = logit 0.67, σβ = (logit 0.89 −
logit 0.67)/2, µθ = logit 0.5 and σθ = (logit 0.8 −
logit 0.5)/2. Thus, the PGD for (p, s) concentrates
around more typical-use scenarios than does the prior
for these parameters. The PGD is completed by
γ ∼ uniform(J) for various specifications of interval
J. Note that one specification is the single-point in-
terval J = [2,2], which corresponds to fixing γ at the
endpoint of I , and hence corresponds to a partially
frequentist evaluation of coverage. Note also that the
average interval lengths do not depend on the speci-
fication of J for this problem, since the distribution
of the observed data (under the joint distribution of
parameters and data) does not depend on J . Thus,
the average lengths of 0.11 for the na¨ıve interval,
0.33 for the CFCI, and 0.28 for the BPCI apply for
any J .
Table 3 verifies that when J in the PGD and I in
the prior coincide, the Bayesian intervals have LWC
within simulation error of nominal, despite the dis-
crepancy between the uniform priors for (p, s) and
the logit-normal PGDs for (p, s). In contrast, the
Table 3
Empirical coverage probabilities and average lengths for
nominal 95% interval estimators of a prevalence pi. Results
are given for na¨ıve estimator, the CFCI and the BPI. For
each choice of PGD (i.e., choice of interval J), results are
based on 10,000 simulated parameter-data ensembles with a
sample size of n= 500. Simulation standard errors for
coverages are 0.5% or less. Both the CFCI and the BPI
assume an interval range I = (−2,2) for γ
J in PGD: Na¨ıve CFCI Bayes
J = (−2,2) 42% 99% 95%
J = (−3,3) 30% 93% 80%
J = (−1,1) 67% 100% 100%
J = (−1,3) 40% 95% 84%
J = (2,2) 9% 95% 71%
Average length 0.11 0.33 0.28
CFCI approach is indeed quite conservative when I
and J coincide, with labwise coverage of 99% and
average length 17% greater than the BPCI. As ex-
pected, the labwise coverage of both the CFCI and
the BPCI is highly affected by any discrepancy be-
tween I and J . As advertised, the CFCI achieves
conservative coverage in all cases, except for a slight
dip below nominal in the case that J is wider than
(and contains) I . Note, in particular, that the CFCI
achieves nominal coverage when γ is fixed at an end-
point of I, whereas the BPCI coverage drops to 71%
in this setting.
The differences between labwise coverage of BP-
CIs and CFCIs are somewhat hidden in Table 3,
since nominal 95% intervals do not have much “room”
to obtain higher than nominal coverage. Thus, we
also report results for nominal 80% intervals (Table
4). Admittedly, such intervals are seldom reported
in practice (though see Greenland et al., 2000, for
an exception), but they are useful for gauging the
extent to which a given interval estimator is con-
servative. The average lengths of these intervals are
0.069 (na¨ıve), 0.29 (CFCI) and 0.22 (BPCI). When
I and J match, we now see very substantial over-
coverage (96%) for the CFCI, with an average width
30% greater than for the OBPCI. We also see more
clearly the over-coverage that results for both CFCI
and BPCI when J is narrower than I .
The BPCI and the CFCI are constructed to sat-
isfy different criteria, and we are not attempting to
argue than one is better than the other. In particu-
lar, note the tradeoff exhibited in Tables 3 and 4. If
the investigator has an interval of values I in mind
for γ, then the CFCI has a conservatism which may
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Table 4
Empirical coverage probabilities and average lengths for
nominal 80% interval estimators of a prevalence pi. Both the
CFCI and the BPI assume an interval range I = (−2,2) for
γ. The table entries are as per Table 2
J in PGD: Na¨ıve CFCI Bayes
(−2,2) 27% 96% 80%
(−3,3) 19% 83% 59%
(−1,1) 47% 100% 98%
(−1,3) 26% 87% 69%
(2,2) 4% 80% 31%
Average length 0.069 0.29 0.22
be appealing: at least nominal coverage can be ob-
tained with respect to any averaging across values
in I , including the selection of single points. On the
other-hand, if labwise coverage with respect to the
Uniform(I) distribution is at issue, then the BPCI
will be shorter on average, and have correct cov-
erage. We do emphasize that this correct coverage
constitutes a calibration property of the BPCI which
the CFCI does not possess. That is, without doing
simulation, we do not know to what extent the CFCI
based on interval I will exhibit higher than nomi-
nal labwise coverage when the PGD is based on I .
But we do know automatically that the BPCI using
I in the prior will exhibit correct labwise coverage
when the PGD is based on I . Thus, the BPCI is an-
chored via the investigator’s knowledge that exactly
nominal coverage would be obtained in a sequence
of studies with PGD equal to the prior, and presum-
ably at least nominal coverage would eventually be
attained in a sequence of studies in which the sup-
port of the prior contains the PGD. In this sense,
posterior coverage is conservative precisely when the
prior is conservative relative to the PGD. The CFCI
labwise coverage has a more murky connection to
the PGD, which is the price it pays for obtaining
correct frequentist coverage at the endpoints of the
prior interval I .
4.2 Example: Case-Control Study
with Misclassification
Consider an unmatched case-control study of the
association of a disease indicator Z and a binary ex-
posure indicator X , with X subject to independent
nondifferential misclassification. Let r0 =
Pr(X = 1|Z = 0) and r1 = Pr(X = 1|Z = 1) be the
prevalences of actual exposure among nondiseased
and diseased source population members, and let
SN = Pr(X∗ = 1|X = 1) and SP = Pr(X∗ = 0|X =
0) be the sensitivity and specificity of the expo-
sure classification in the study. The numbers ap-
parently exposed among the n0 nondiseased con-
trols and n1 diseased cases in the study are mod-
eled as Yi ∼ Bin(ni, θi) for i = 0 and i = 1 respec-
tively, with θi = riSN + (1− ri)(1− SP) = Pr(X
∗ =
1|Z = i). If all four parameters (r0, r1,SN ,SP) are
unknown, then this model is not identified by the ob-
served counts (y1, y0, n1 − y1, n0 − y0). Bayesian in-
ference under this model is considered by Gustafson,
Le and Saskin (2001), Gustafson (2003), Greenland
(2005), Chu et al. (2006) and Gustafson and Green-
land (2006a), among others.
We consider prior distributions and PGDs of the
following form: A bivariate normal distribution for
the logit prevalences (logit r0, logit r1), with correla-
tion ρ and identical marginals (mean µ and variance
τ2). The log-odds ratio, β = logit(r1)− logit(r0), is
then distributed as N{0, (1 − ρ)2τ2}. The correla-
tion is essential to reflect the fact that information
about the exposure prevalence in one group would
alter bets about the prevalence in the other group,
due to prior information about β (Greenland, 2001).
SN and SP are here taken as independent of the ex-
posure prevalences and each other, however, with
SN ∼ Beta(aN , bN ) and SP ∼ Beta(aP , bP ); more
realistic priors might allow dependent SN and SP
(Chu et al., 2006; Greenland and Lash, 2008), or one
could instead reparameterize the problem to make
prior independence reasonable (Greenland, 2009).
Bayesian computation is readily implemented via
the efficient algorithm of Gustafson, Le and Saskin
(2001). While this algorithm takes advantage of struc-
ture imbued by assigning uniform priors on preva-
lences, we can use importance sampling to adapt the
algorithm output to the present prior specification.
As an example, m= 10,000 parameter-data ensem-
bles with n1 = n2 = 500 are drawn from the PGD
based on µ = −2.3, τ = 1.17, ρ = 0.76, aN = aP =
18, aN = aP = 4. These choices produce a 95% logit-
symmetric interval for each ri of (0.01,0.50) and a
95% log-symmetric interval for eβ of (0.2,5.0). Also,
the modes of the SN and SP distributions are 0.85,
with 95% logit-symmetric intervals of (0.637,0.946).
For each data set, seven interval estimates for β
are constructed:
(i) the standard FCI assuming no misclassifica-
tion;
(ii) an FCI derived by taking SN = 0.85 and
SP = 0.85 as known values;
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(iii) the omniscient BPCI arising when the prior
distribution coincides with the PGD;
Nonomniscient BPCIs with priors based on cor-
rect specification of (µ, τ, ρ) but:
(iv) aN = aP = 9.5, bN = bP = 2.5 (keeping the
prior modes on SN and SP at 0.85 but making the
distribution more diffuse);
(v) aN = aP = 26.5, bN = bP = 5.5 (modes at
0.85 but overly concentrated);
(vi) aN = aP = 23.5, bN = bP = 8.5 (still overly
concentrated and modes shifted down to 0.75);
(vii) aN = aP = 28.5, bN = bP = 3.5 (still overly
concentrated and modes shifted up to 0.95).
Empirical properties of the interval estimators (at
the nominal 95% level) are described in Table 5.
In the previous example, the joint posterior den-
sity was a product of the marginal posterior den-
sity for the two parameters appearing in the like-
lihood function and the marginal posterior density
(equal to the prior density) for the one parameter
not in the likelihood. This factorization simplified
the mathematics of how the prior influences the pos-
terior distribution of the target parameter. In the
present example, however, the structure of the prob-
lem is more nuanced. As emphasized by Gustafson,
Le and Saskin (2001), the support of the two pa-
rameters not in the likelihood, (SN ,SP), depends
on the values of the two parameters in the likeli-
hood, (θ0, θ1), since by construction 1− SP and SN
must straddle both θi values. To some extent then,
the posterior distribution of (SN ,SP) can depend
on the data, even though these parameters do not
appear in the likelihood function. Gustafson (2005a)
Table 5
Empirical labwise properties of nominal 95% interval
estimators for a log odds ratio β based on 10,000 simulated
parameter-data ensembles. The simulation standard errors
for coverage are less than 0.5%. Results for estimator (ii)
are based only on the 81% of ensembles for which the method
works
Coverage Avg. length
(i)-FCI 44% 0.60
(ii)-FCI 81% 2.20
(iii)-OBPI 95% 2.02
(iv)-NBPI 95% 2.12
(v)-NBPI 94% 1.94
(vi)-NBPI 95% 2.32
(vii)-NBPI 87% 1.56
discusses such indirect learning about parameters in
nonidentified models in more general terms.
Given that the data can provide some informa-
tion about (SN ,SP), one might anticipate that the
NBPCI coverage would be less sensitive to the choice
of prior than in a situation without any indirect
learning. The results in Table 5 bear this out, with
the coverage of nominal 95% NBPIs ranging from
87% to 95% across the priors considered. In accord
with theory, the OBPCI coverage is within simula-
tion error of nominal, which can be regarded as a
check that our scheme for posterior computation is
working adequately (see Cook, Gelman and Rubin,
2006, for elaboration).
While the link between (SN ,SP) and (θ0, θ1) is
exploited to advantage under a Bayesian analysis,
it is problematic for the FCI based on taking SN
and SP as fixed values less than one. In particu-
lar, the FCI is not defined for data sets with one
or both θˆi falling outside the interval (1− SP ,SN ).
Moreover, this can happen via sampling variation
even if the postulated values of (SN ,SP) happen
to be correct. Tu, Litvak and Pagano (1994, 1995)
discussed this problem, and offered some mitigating
strategies when exposure prevalence (say, in a sin-
gle population) is the inferential target of interest.
Such strategies yield interval estimates for preva-
lence with an endpoint at zero or one, which lim-
its their utility for odds-ratio inference. In our case,
the results for estimator (ii) in Table 5 are based
on only the 81% of sampled parameter-data ensem-
bles not giving rise to the aforementioned problem.
Perversely, this method is failing in situations where
the data are most suggestive that the guessed val-
ues of (SN ,SP) might be wrong. Put another way,
the FCI fails on data sets where Bayesian intervals
may do particularly well via more prior-to-posterior
updating of (SN ,SP).
As a final point concerning this example, we rec-
ognize that it is quite reasonable to also study the
frequentist properties of the Bayesian interval esti-
mator. This can become quite computationally bur-
densome, however, if evaluation of frequentist cover-
age at many points in the parameter space is desired:
each point necessitates simulation of many data sets,
and each data set may require many MCMC iter-
ations in order to compute the interval estimate.
Rather than pursuing this course, we note that the
simulation of parameter-data ensembles as used to
evaluate labwise coverage also yields information
about frequentist coverage.
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Thus, say that the frequentist coverage for param-
eter vector θ∗ is of interest. If m parameter-data en-
sembles are simulated, then we might consider the
proportion α of ensembles for which θ is closest to
θ∗ in some sense. Then the empirical coverage for
this subset of ensembles approximates the frequen-
tist coverage at θ∗, with the approximation improv-
ing as α→ 0 and mα→∞. Admittedly, it may be
computationally prohibitive to make the approxi-
mation error very small, so we refer to the reported
coverage as “near-frequentist coverage” around θ∗.
Notwithstanding its approximate nature, this can
still reveal trends in frequentist coverage across the
parameter space.
To apply this to the present example, we extend
the simulation size to m= 100,000 parameter-data
ensembles, and set α= 0.01. Various points θ∗ in the
parameter space are considered, by fixing r0 = 0.10,
r1 = 0.15, and then setting SN and SP at values
corresponding to specific prior quantiles. Thus, we
investigate how the frequentist coverage depends on
the compatibility between the prior and the true
SN and SP values. Results appear in Table 6. We
see under-coverage for SP values which are low in
relation to the prior, and over-coverage when SP
or SN is high in relation to the prior. Generally,
however, the variation in frequentist coverage as SN
and SP values move around the region supported by
the prior distribution seems quite modest.
5. RECOMMENDATIONS
The above arguments and illustrations are intended
to summarize and explain in simple form several
practical recommendations that we and others have
reached in the course of numerous theoretical stud-
ies, simulations and real applications. Like others
before us, we first recommend forming prior dis-
tributions and then reporting Bayesian interval es-
timates for parameters of interest, particularly in
nonidentified model contexts. Based on our investi-
gations, however, we further suggest that a special
form of sensitivity analysis be carried out as well.
Sensitivity analysis is conducted in much applied
work; typically this involves reporting multiple in-
ferences corresponding to multiple models and (for
Bayesians) multiple prior distributions. While these
analyses are often better than standard reports of
results from just one model, the resulting collection
of interval estimates leads to problems of summa-
rization and interpretation of the collection. Thus,
we recommend instead that one start with a sin-
gle, relatively inclusive “covering” prior distribution
that subsumes the diversity of opinions and possi-
bilities for the parameters. Then, as a safeguard, we
would evaluate the labwise coverage of Bayesian in-
tervals arising from this prior, for a variety of PGDs
differing somewhat from the prior. If the coverage
does not fall much below nominal as the PGD de-
viates from the prior, then we may argue that our
statistical procedure is probably (in the subjective
judgmental sense) at least roughly calibrated, in the
across-study sense of labwise coverage. Otherwise,
we may consider ourselves alerted to a potentially
serious miscalibration.
Table 3, in the context of prevalence surveys with
nonresponse, provides one example of studying the
sensitivity of labwise coverage as the PGD deviates
from the prior distribution. We close with a further
example from a specific and well-developed scientific
context.
5.1 Example: Silica Exposure and Lung Cancer
We revisit the investigation of Steenland and Green-
land (2004) on the relationship of silica exposure
Table 6
Near-frequentist coverage in the case-control study with misclassification example
SP
∗
= 0.63 SP
∗
= 0.77 SP
∗
= 0.83 SP
∗
= 0.88 SP
∗
= 0.95
SN ∗ = 0.63 90% 95% 97% 97% 98%
SN ∗ = 0.77 92% 98% 99% 99% 99%
SN ∗ = 0.83 93% 99% 99% 99% 99%
SN ∗ = 0.88 92% 99% 99% 99% 99%
SN ∗ = 0.95 93% 98% 99% 99% 98%
NOTE: Evaluation is for parameter values θ∗ given by r∗ = (0.10,0.15) and the indicated values of (SN ∗,SP∗), using α= 0.01
of the m = 100,000 simulated parameter-data ensembles in each instance. The chosen values for (SN ∗,SP∗) correspond to
2.5th, 25th, 50th, 75th and 97.5th percentiles of the prior distribution.
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to lung cancer. In a cohort of 4626 industrial sand
workers with high silica exposure, 109 lung-cancer
deaths were observed, compared to an expected count
of 68.1 under the null hypothesis of no association
between silica exposure and lung cancer. This com-
parison of the cohort to US population data is ad-
justed for age, race, calendar time and sex. It is not
adjusted for smoking status though, because smok-
ing histories were not collected for this cohort.
Steenland and Greenland used prior information
derived from other studies in order to remedy this
situation using both Monte Carlo sensitivity analy-
sis (MCSA) and Bayesian analysis. To describe this
analysis, let β1 be the log relative risk of lung-cancer
death for silica exposure versus no exposure, within
strata defined by smoking behavior, and let β2 and
β3 be log relative risks for current smokers compared
to never smokers, and former smokers compared to
never smokers. Assuming a log-linear model with-
out products between silica exposure and smoking
effects, the observed death count can be regarded as
a Poisson realization with log-mean λ, where
λ= c+ β1 + log(p1 + p2e
β2 + p3e
β3)
− log(q1 + q2e
β2 + q3e
β3).
Here c is a known offset obtained from population
data (c = log 68.1 in the present example), while
(p1, p2, p3) and (q1, q2, q3) are probability distribu-
tions over (never, current, former) smokers, in the
exposed and unexposed populations respectively.
This is a highly nonidentified model, with nine un-
known parameters involved in the mean function.
Identification of the target parameter β1 can only be
obtained via a strong assumption, for example, that
smoking behavior and occupational silica exposure
are unassociated, that is, (p1, p2, p3) = (q1, q2, q3),
which is known to be false. Thus, a far more prin-
cipled analysis combines the Poisson model for data
along with prior distributions for (β1, β2, β3), (p1, p2,
p3) and (q1, q2, q3).
Based on data from a large cohort study of smok-
ing and lung cancer, Steenland and Greenland took
β2 ∼ N(log(23.6),0.094
2) and independently β3 ∼
N(log(8.7),0.0942). They used smoking data on a
small sample of 199 workers to inform the prior p∼
Dirichlet(199 × (0.26,0.40,0.34)), and used a large
national survey to inform the prior on q. This survey
involved 56,000 subjects, but to account for various
uncertainties it was discounted by a factor of four
to yield the prior q ∼ Dirichlet(14,000× (0.34,0.35,
0.31)). Steenland and Greenland used a very diffuse
prior on β1. This is not appropriate for investigating
labwise coverage, however, as some data sets simu-
lated from parameters generated under this prior
will have implausibly low (i.e., zero) death counts,
while others will have implausibly large counts. Thus,
for present purposes we take the prior β1 ∼
N [0,{ln(5)/2}2], which puts most of its weight on
relative risks between 1/5 and 5. This completes
specification of the prior distribution.
Bayesian computation for the present situation is
readily implemented in a two-stage manner. First,
an approximate posterior sample is simulated by
drawing λ values “as if” λ had a flat prior, and in-
dependently drawing (β2, β3, p1, p2, p3, q1, q2, q3) val-
ues from their prior distribution. Second, this pos-
terior sample is “made exact” via importance sam-
pling, which recognizes the actual prior distribu-
tion in the (λ,β2, β3, p1, p2, p3, q1, q2, q3) parameter-
ization. Note that omitting the second step corre-
sponds to the MCSA in Steenland and Greenland.
In the present example this second step has negligi-
ble impact, though in general importance sampling
can be used to convert MCSA inferences to fully
Bayesian inferences in situations where the two do
not agree so closely.
Applied to the cohort data, a 95% equal-tailed
BPCI for exp(β1) is (1.12,1.73), which is very simi-
lar to the interval reported by Steenland and Green-
land using their slightly different prior. For compar-
ison, the analysis which ignores the confounding ef-
fect of smoking gives the interval (1.31,1.91). This
result is based on the same prior for β1 as above,
with the presumption that (p1, p2, p3) = (q1, q2, q3).
Thus, the impact of acknowledging smoking as a
confounder is to push the interval estimate for β1
toward (but not across) the null, and to widen the
interval by about 15%. This widening is somewhat
modest, since there is relatively good prior data about
smoking effects and smoking behavior in the two
populations and the association of smoking with sil-
ica exposure in these data appears to be small.
We know that BPCIs based on this prior will have
correct labwise coverage for a PGD equal to the
prior. We wish to see how far the coverage devi-
ates from nominal as the PGD deviates from the
prior. We thus examine eight PGDs, starting with
the prior and considering all possible combinations
of:
(i) shifting the prior mean for β2 left or right by
one prior standard deviation;
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Table 7
Labwise coverage of 95% Bayesian intervals for β1 as the
PGD varies, in the silica and lung cancer example. The first
row gives coverage when the PGD equals the prior.
The remaining eight rows give coverage when the PGD is an
alteration of the prior. The three-character code describes
the alteration. The first character (+ or −) indicates
whether the mean of β2 is increased or decreased, the second
character does the same for the mean of β3, and the third
character (p or q) indicates whether the prior on p or the
prior on q is discounted. Results are based on 100,000
realizations, giving simulation error for coverage less than
0.1%
PGD Coverage %
Prior 94.8
−− p 92.6
−− q 94.8
−+ p 93.1
−+ q 95.2
+− p 92.0
+− q 94.5
++ p 92.4
++ q 94.8
(ii) shifting the prior mean for β3 left or right by
one prior standard deviation;
(iii) discounting the prior on (p1, p2, p3) by a fac-
tor of two or (further) discounting the prior on (q1, q2,
q3) by a factor of two.
Table 7 gives coverage results using 95% equal-
tailed BPIs for β1. When the PGD equals the prior,
the labwise coverage is within simulation error of
nominal, as theory dictates. As the model is highly
nonidentified, we are not surprised to see lower than
nominal coverage for most of the PGDs considered.
We are pleasantly surprised, however, to see that the
loss of coverage is very mild. This adds credence to
the Bayesian results given by Steenland and Green-
land (2004).
Based on examples as well as theoretical and sim-
ulation studies, we recommend that PGD sensitiv-
ity analysis be used when inference based on non-
identified models is required. No important sensi-
tivity was seen in the preceding example. Nonethe-
less, high sensitivity to plausible PGD specifications
would have suggested that the full model (including
those for the prior distribution and data-generating
mechanism) had inadequately captured posterior un-
certainty given the actual prior uncertainty of the
analysts, and that interval estimates from the model
could be seriously miscalibrated. Hence, as with failed
regression diagnostics, we would find ourselves ad-
vised to revise our model rather than rely on it.
Of course, this advice raises classic issues of the
impact of post-data model revision based on diag-
nostics, long recognized as a challenge for applied
Bayesians as well as for applied frequentists (Box,
1980). We thus regard these issues as an important
direction for further research in our proposed ap-
proach.
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